Global Neurosurgical Devices Market: Drivers, Opportunities, Trends, and Forecasts: 2017–2023
Overview: Neurosurgery is a complex medical specialty concerned with individuals suffering from neuro-related diseases and disorders. The nervous system is prone to several diseases that affect brain, spine, peripheral nerves, and spinal cord. The symptoms such as muscle weakness, seizures, perception, partial or complete analysis, cognition or emotional state, loss of bowel, and bladder control are due to the various neurological problems. Neurosurgery is the most advanced and modernized method for diagnosis and treatment, which includes computed tomography, magnetic resonance imaging (MRI), computer assisted imaging, stereotactic radiosurgery, and magnetoencephalography. Some of the common neurosurgeries include craniotomy, microsurgery, oncological neurosurgery, neuro-endoscopy (endoscopic endonasal surgery), and stereotactic neurosurgery. There is a wide availability of neurosurgical devices such as neurostimulators, flow diverters, CSF shunts, neuroendoscopes, access devices, and support devices that are used in performing neurosurgeries.
There are about 1 billion individuals, which is nearly 13.46% of the global population, suffering from neurological disorders. Some of the most prevalent neurological disorders are strokes, multiple sclerosis, epilepsy, brain injuries, Alzheimer and Parkinson diseases, and neuro-infections. Neurological disorders cause more than 10% of deaths worldwide. Cerebral disorders are among the most common neurological disorder and are most commonly found in women. The change in lifestyles and stress have resulted in the development of a range of disorders like mood and anxiety disorders. According to the estimates by WHO, more than 350 million people are suffering from depression globally. According to Brain Aneurysm Foundation, there are about 50 million brain aneurysm-related deaths every year, out of which half of the deaths occur in individuals who are aged below 50 years.
The factors such as increased prevalence of neurological disorders, increasing awareness about new technologies, presence of large pool of patients in emerging markets, and advent of new innovative neurosurgical devices such as flow diversion devices, neuroendovascular stents, liquid embolic, clot retrieval, and balloon catheters are expected to drive the market growth during the forecast period. The market is expected to witness a substantial growth due to the emergence of neuro-interventional technology that has eventually fueled the innovation of many neurosurgical devices with the involvement of minimally invasive technique. The markets in India, Brazil, and China are expected to grow at a rapid pace during the forecast period mainly due to the presence of patients affected with various neurosurgical disorders.
Neurosurgical devices continue to demonstrate substantial improvements in patient outcomes by delivering high-quality and life-sustaining treatment. This factor provides huge potential for market growth in both developed and developing countries with a wide range of opportunities. Vendors are investing hugely in R&D activities in the development of new products to gain major market share globally.
Market Analysis: The “Global Neurosurgical Devices Market” is estimated to witness a CAGR of 10.5% during the forecast period 2017–2023. The Neurosurgical Devices market is analyzed based on three segments – product type, end-users, and regions.
Product Analysis: The “Global Neurosurgical Devices Market” segments include Neurostimulation Devices, Neurointerventional Devices, CSF Management Devices, Neuro Surgical Navigation Systems, and Other Neurosurgical Devices. Neurostimulation Devices is dominating with the presence of advanced neurostimulation devices and availability of clinical data regarding the safety & efficacy of the devices. This enables surgeons to adopt methods for the treatment of neurological disorders. Therefore, opportunities for growth in the emerging countries of LATAM and APAC remain vast. Increasing adoption of MI surgeries in treating neurological disorders, particularly in elderly and the growing availability of devices contribute to the growth of the market.
Regional Analysis: The regions covered in the report are the Americas, EMEA, and Asia Pacific (APAC). The Americas is set to be the leading region for the neurosurgical devices market growth followed by EMEA. There has been a significant increase in the number of individuals undergoing treatment for various neurosurgical procedures in the US. For instance, according to the American Academy of Neurology, neurological disorders accounted for 7% of all global diseases in 2014.
Europe accounted for the second largest market with chronic pain being one of the major complications with rising burden of cerebral disorders cases. In 2015, the public spending on healthcare in Europe amounted to 18% of the overall government expenditure. The expenditure on chronic pain care with neurostimulation devices is directly reimbursed to hospitals within the NHS. Clinical evidence of neurosurgical devices, when compared to other treatment such as drug therapy, is expected to increase during the forecast period.
The APAC neurosurgical devices market revenue is expected to reach $2.4 billion by 2023, growing at a CAGR of 13% during the forecast period 2016–2023. The factors such as high prevalence of neurological diseases, presence of a large pool of patients, increase in disposable income, and rise in awareness about treatment for complex neurosurgeries are owing to a substantial growth in the market. Also, the increase in government spending in healthcare, infrastructure, research centers, and the establishment of manufacturing facilities by major vendors are influencing high growth in the market.
Key Players: Boston Scientific Corp., DePuy Synthes, Inc., Integra LifeSciences Holdings Corp., Medtronic PLC, Stryker Corp., and other predominate & niche players.
Competitive Analysis: At present, the market is dominated by Neurostimulation Devices having the maximum number of procedures and sales of neurostimulators in the market. Vendors are focusing on investing a huge amount in R&D activities to develop new innovative products in the market with newer application to offer novel devices. Most of the vendors in the market are focused on expanding their business by mergers & acquisitions, through partnerships, and trade shows. Big players such as Boston Scientific Corp., DePuy Synthes, Inc., Integra LifeSciences Holdings Corp., Medtronic PLC, and Stryker Corp. along with the collaboration with other universities and neurological research centers for clinical trials of neurology diseases are coming up with new neurosurgical devices in the market, which are expected to grow tremendously during the forecast period. Significant investments in R&D and increasing awareness about complex neurosurgical procedures in the market are expected to boost the market growth.
Benefits: The report provides complete details about the usage and adoption rate of neurosurgical devices in various neurology diseases and regions. With that, key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, government initiatives towards the neurosurgical devices adoption in the upcoming years along with the details of commercial neurosurgical devices available in the market. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
1.1 Report Scope
1.2 Market Definitions
1.3 Research Methodology
1.4 Report Assumptions and Declarations
3 Market Positioning
3.1 Total Addressable Market (TAM): Neurosurgical Industry
3.1.1 Market Overview
3.1.2 Major Trends
3.1.3 PEST Analysis
3.2 Segmented Addressable Market (SAM)
3.3 Related Markets
4 Market Outlook
Value Chain Analysis
4.3 Market Segmentation
4.4 Porter 5 (Five) Forces Analysis
4.5 Raw Material Analysis
4.6 Patents Analysis
5.2 Market Segmentation
5.3 Market Dynamics
5.3.4 DRO – Impact Analysis
Neurosurgical Market by Application: Market Size and Analysis
6.2 Neurostimulation devices
6.3 Interventional neurology device
6.4 Cerebrospinal fluid devices
6.5 Neurosurgery devices
6.6 Neurosurgical navigation systems
7 Neurosurgical Market by Regions: Market Size and Analysis
7.2 The Americas
7.3 The EMEA Region
The APAC region
7.5 Rest of the World
8 Vendor Profiles
8.1 Boston Scientific Corp.
8.2 DePuy Synthes Inc. (a subsidiary of Johnson & Johnson)
8.3 Medtronic PLC
8.4 Stryker Corp.
8.5 Integra LifeSciences Corp.
(Overview, products/services, geographic revenues, recent developments, business focus, SWOT analysis and business strategy for all vendors)
Companies to Watch For
9.1 MicroVention Inc.
9.2 Penumbra Inc.
9.3 Cyberonics Inc
(Overview, product coverage and potential, geographic exposure, recent developments, and business strategy for all players)
10 Competitive Landscape
10.1 Competitor Product & Geography Benchmarking
10.2 Market Landscape
10.2.1 Key Strategies Adopted
11 What Our Peers Are Estimating
11.1 Publisher 1
11.3 Publisher 3
TABLE 1 GLOBAL NEUROSURGICAL DEVICES MARKET BY TYPES, 2016–2023 ($MILLION) 40
TABLE 2 DRO OF NEUROSTIMULATION DEVICES MARKET 45
TABLE 3 CLINICAL TRIALS OF NEUROINTERVENTIONAL DEVICES 47
TABLE 4 DRO OF NEUROINTERVENTIONAL DEVICES MARKET 53
TABLE 5 DRO OF CSF MANAGEMENT DEVICES MARKET 58
TABLE 6 DRO OF NEUROSURGICAL NAVIGATION SYSTEM MARKET 61
TABLE 7 DRO OF OTHER NEUROSURGICAL DEVICES MARKET 64
TABLE 8 GLOBAL NEUROLOGICAL DEVICES MARKET BY END-USERS 70
TABLE 9 GLOBAL NEUROSURGICAL DEVICES MARKET REVENUE BY REGIONS FORECAST, 2016–2023 ($MILLION) 73
TABLE 10 DRO (AMERICAS) 75
TABLE 11 DRO (EMEA) 77
TABLE 12 DRO (APAC) 79
TABLE 13 GLOBAL NEUROSURGICAL DEVICES MARKET BY VENDOR RANKING, 2016 82
TABLE 14 MEDTRONIC PLC: PRODUCT OFFERINGS 83
TABLE 15 MEDTRONIC PLC: RECENT DEVELOPMENTS 84
TABLE 16 STRYKER CORP.: PRODUCT OFFERINGS 89
TABLE 17 STRYKER CORP.: RECENT DEVELOPMENTS 90
TABLE 18 DEPUY SYNTHES, INC: PRODUCT OFFERINGS 96
TABLE 19 DEPUY SYNTHES, INC: RECENT DEVELOPMENTS 97
TABLE 20 INTEGRA LIFESCIENCES CORP.: PRODUCT OFFERINGS 103
TABLE 21 INTEGRA LIFESCIENCES CORP.: RECENT DEVELOPMENTS 104
TABLE 22 BOSTON SCIENTIFIC CORP.: PRODUCT OFFERINGS 110
TABLE 23 BOSTON SCIENTIFIC CORP.: RECENT DEVELOPMENTS 110
TABLE 24 TERUMO CORP.: SNAPSHOT 117
TABLE 25 TERUMO CORP.: RECENT DEVELOPMENTS 117
TABLE 26 ST. JUDE MEDICAL INC.: SNAPSHOT 119
TABLE 27 ST. JUDE MEDICAL INC.: RECENT DEVELOPMENTS 119
TABLE 28 B. BRAUN MELSUNGEN AG: SNAPSHOT 121
TABLE 29 B. BRAUN MELSUNGEN AG: RECENT DEVELOPMENTS 121
TABLE 30 PENUMBRA INC.: SNAPSHOT 123
TABLE 31 BALT EXTRUSION S.A.: SNAPSHOT 125
TABLE 32 CYBERONICS INC.: SNAPSHOT 126
TABLE 33 CYBERONICS INC.: RECENT DEVELOPMENTS 126
CHART 1 NEUROSURGICAL DEVICES MARKET SEGMENTATION 11
CHART 2 NEUROLOGICAL SYMPTOMS FOR UNRUPTURED ANEURYSM 15
CHART 3 PEST ANALYSIS OF GLOBAL NEUROSURGICAL DEVICES MARKET 17
CHART 4 RESEARCH METHODOLOGY OF GLOBAL NEUROSURGICAL DEVICES MARKET 19
CHART 5 GLOBAL MEDICAL DEVICES MARKET SEGMENTATION 21
CHART 6 WORLDWIDE NEUROSURGICAL DEVICES MARKET REVENUE, 2016–2023 ($MILLION) 23
CHART 7 PORTER 5 FORCES ON GLOBAL NEUROSURGICAL DEVICES MARKET 27
CHART 8 KEY DEVELOPMENTS AND INVENTIONS IN NEUROSURGICAL PROCEDURES 29
CHART 9 DRO – IMPACT ANALYSIS OF GLOBAL NEUROSURGICAL DEVICES MARKET 38
CHART 10 KEY STAKEHOLDERS 38
CHART 11 GLOBAL NEUROSURGICAL DEVICES MARKET BY TYPE SEGMENTATION, 2016 (%) 40
CHART 12 WORLDWIDE NEUROSTIMULATION DEVICES MARKET BY REVENUE 2017–2023 ($MILLION) 41
CHART 13 GLOBAL NEUROSTIMULATION DEVICES MARKET BY SEGMENTATION 42
CHART 14 GLOBAL NEUROSTIMULATION DEVICES MARKET BY SEGMENTATION, 2016 (%) 44
CHART 15 WORLDWIDE NEUROINTERVENTIONAL DEVICES MARKET BY REVENUE, 2017–2023 ($MILLION) 47
CHART 16 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY SEGMENTATION 48
CHART 17 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY SEGMENTATION, 2016 (%) 52
CHART 18 WORLDWIDE CSF MANAGEMENT DEVICES MARKET BY REVENUE, 2017–2023 ($MILLION) 56
CHART 19 GLOBAL CSF MANAGEMENT DEVICES MARKET BY SEGMENTATION 56
CHART 20 GLOBAL CSF MANAGEMENT DEVICES MARKET BY SEGMENTATION, 2016 (%) 57
CHART 21 WORLDWIDE NEUROSURGICAL NAVIGATION SYSTEM MARKET BY REVENUE, 2017–2023 ($MILLION) 60
CHART 22 WORLDWIDE OTHER NEUROSURGICAL DEVICES MARKET BY REVENUE, 2017–2023 ($MILLION) 62
CHART 23 GLOBAL OTHER NEUROSURGICAL DEVICES MARKET BY SEGMENTATION 63
CHART 24 GLOBAL NEUROSURGICAL DEVICES MARKET BY END-USER SEGMENTATION, 2016 (%) 66
CHART 25 GLOBAL NEUROSURGICAL DEVICES MARKET BY GEOGRAPHICAL SEGMENTATION, 2016 (%) 72
CHART 26 GLOBAL NEUROSURGICAL DEVICES MARKET BY GEOGRAPHICAL SEGMENTATION, 2023(%) 73
CHART 27 NEUROSURGICAL DEVICES MARKET REVENUE IN THE AMERICAS, 2016–2023 ($MILLION) 74
CHART 28 NEUROSURGICAL DEVICES MARKET REVENUE IN THE EMEA REGION, 2016–2023 ($MILLION) 77
CHART 29 NEUROSURGICAL DEVICES MARKET REVENUE IN THE APAC REGION, 2016–2023 ($MILLION) 79
CHART 30 MEDTRONIC PLC: OVERVIEW SNAPSHOT 85
CHART 31 MEDTRONIC PLC: BUSINESS UNITS 85
CHART 32 MEDTRONIC PLC: GEOGRAPHICAL PRESENCE 86
CHART 33 MEDTRONIC PLC: SWOT ANALYSIS 87
CHART 34 STRYKER CORP.: OVERVIEW SNAPSHOT 91
CHART 35 STRYKER CORP.: BUSINESS UNITS 91
CHART 36 STRYKER CORP.: GEOGRAPHIC PRESENCE 92
CHART 37 STRYKER CORP.: SWOT ANALYSIS 94
CHART 38 DEPUY SYNTHES: OVERVIEW SNAPSHOT 98
CHART 39 DEPUY SYNTHES, INC: BUSINESS UNITS 99
CHART 40 DEPUY SYNTHES, INC: GEOGRAPHIC PRESENCE 100
CHART 41 DEPUY SYNTHES: SWOT ANALYSIS 102
CHART 42 INTEGRA LIFESCIENCES CORP.: OVERVIEW SNAPSHOT 105
CHART 43 INTEGRA LIFESCIENCES CORP.: BUSINESS UNITS 106
CHART 44 INTEGRA LIFESCIENCES CORP.: GEOGRAPHIC PRESENCE 106
CHART 45 INTEGRA LIFESCIENCES CORP.: SWOT ANALYSIS 107
CHART 46 BOSTON SCIENTIFIC CORP.: OVERVIEW SNAPSHOT 111
CHART 47 BOSTON SCIENTIFIC CORP.: BUSINESS UNIT 112
CHART 48 BOSTON SCIENTIFIC CORP.: GEOGRAPHIC PRESENCE 113
CHART 49 BOSTON SCIENTIFIC CORP.: SWOT ANALYSIS 114
Boston Scientific Corp., DePuy Synthes Inc. (a subsidiary of Johnson & Johnson), Medtronic PLC, Stryker Corp., Integra LifeSciences Corp., MicroVention Inc., Penumbra Inc., Cyberonics Inc.